The Montreux Healthcare Fund’s core asset, The Active Care Group (ACG), is the first UK neurological healthcare provider to invest in RehaCom software.

The German based software assists with traumatic brain injuries, stroke, multiple sclerosis, depression, and visual deficits. It was set up as an alternative to traditional pen and paper methods of cognitive rehabilitation and has the potential to benefit service users of all ages at various stages of their rehab journey.

The benefits of RehaCom software means that ACG therapists can work with several service users at once. Recent results also showed that a 39-year-old resident within an ACG facility increased his periods of concentration after 10 sessions of RehaCom, with his visual abilities almost back to pre-injury level.

Montreux Capital Management UK CEO, Oliver Harris, said “The introduction of the RehaCom software into The Active Care Group highlights the invocation of the group. In procuring this software they continue to ensure the highest quality of care for its services users, patients, and staff which is a core strategy of ACG and The Montreux Healthcare Fund.”

Further information about RehaCom’s software can be found on the ACG website at

Find Us

Thameside House
Hurst Road
East Molesey

T: + 44 (0) 1932 860 140

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.